SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Pharma’s partner gets USFDA’s nod for generic methadone hydrochloride tablets

07 Aug 2018 Evaluate

Glenmark Pharmaceuticals’ partner Elite Pharmaceuticals, Inc., a US specialty pharmaceutical company, has received approval from the US Food and Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for methadone hydrochloride 5 mg and 10 mg tablets.

Methadone is indicated for the management of pain severe enough to require daily, around-the-clock long-term opioid treatment and for which alternative treatment options are inadequate. Methadone can also be used for maintenance treatment of opioid addiction (heroin or other morphine-like drugs) in conjunction with appropriate social and medical services.

Glenmark Pharmaceuticals, Inc., Elite's marketing alliance partner, will sell and distribute methadone for Elite for which Elite will receive manufacturing and license fees. Based on Quintiles IMS Health data, the annual retail sales for the brand and generic products were around $30 million.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).


Glenmark Pharma Share Price

2372.00 -1.75 (-0.07%)
07-May-2026 11:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1829.70
Dr. Reddys Lab 1305.95
Cipla 1370.75
Zydus Lifesciences 939.00
Lupin 2469.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×